| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
DRC develops and uses the latest technology, proven systems, and quality processes to find easier, faster, and better solutions to meet our clients increasingly sophisticated information requirements.
dynip is a Sarnia, ON-based company in the Software and Internet sector.
JobDiva is the top recruiting and staffing ATS, CRM, and VMS focused on your success! JobDiva offers recruiters unlimited free training of its staffing & recruiting solution, including resume aggregation and applicant tracking. Request your free demo w...
DrivenData hosts data science competitions to build a better world, bringing cutting-edge predictive models to organizations tackling the worlds toughest problems.